Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montalescot

Showing results (141-150 of 143) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 143 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 2, 2025
Mass balance and metabolite profiling of <sup>14</sup>C-Zalunfiban in humans following single-dose subcutaneous administrationRobert B MacArthur, Sem A O F Rikken, Spandana R Vootukuri, et al.
Clinical Pharmacology and Therapeutics|May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivityS A Scott, J-P Collet, U Baber, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Pageof 15

Showing results (141-150 of 143) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 143 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 2, 2025
Mass balance and metabolite profiling of <sup>14</sup>C-Zalunfiban in humans following single-dose subcutaneous administrationRobert B MacArthur, Sem A O F Rikken, Spandana R Vootukuri, et al.
Clinical Pharmacology and Therapeutics|May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivityS A Scott, J-P Collet, U Baber, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Pageof 15